Can tapering clonazepam (benzodiazepine) cause restless legs syndrome?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Tapering Clonazepam Can Cause Restless Legs Syndrome

Yes, tapering clonazepam can cause or worsen restless legs syndrome (RLS) as a withdrawal symptom. This is supported by current clinical guidelines and research evidence.

Mechanism and Evidence

Clonazepam works through GABAergic mechanisms, which have been implicated in RLS pathophysiology 1. When tapering this medication:

  • The American Academy of Sleep Medicine (AASM) suggests against using clonazepam for RLS treatment (conditional recommendation, very low certainty of evidence) 2
  • However, the same guidelines acknowledge that clonazepam has been used for RLS, with sedation noted as a common adverse effect 2
  • Benzodiazepine withdrawal commonly causes rebound symptoms including anxiety, insomnia, irritability, tremors, and sweating 3

The emergence of RLS during benzodiazepine tapering can be explained by:

  1. Disruption of GABA neurotransmission that was previously enhanced by clonazepam
  2. Rebound hyperexcitability in the central nervous system
  3. Sleep architecture changes during withdrawal

Management Approach for Clonazepam Tapering with RLS

Step 1: Implement Proper Tapering Protocol

  • Follow the AASM recommendation of gradual tapering at approximately 0.25 mg per week 3
  • Consider an even slower taper (10-25% reduction every 1-2 weeks) if RLS symptoms emerge
  • Never abruptly discontinue clonazepam after prolonged use

Step 2: Address Emerging RLS Symptoms

If RLS symptoms develop during tapering:

  • Temporarily pause or slow the taper rate until symptoms stabilize
  • Consider adding non-benzodiazepine treatments for RLS:
    • Iron supplementation if ferritin levels are low
    • Gabapentin (100-300 mg at bedtime) which can help both with RLS and withdrawal management 3
    • Vitamin C for mild cases 2

Step 3: Consider Alternative Treatments

For persistent RLS during tapering:

  • Avoid dopamine agonists like pramipexole or ropinirole as first-line therapy despite some evidence of effectiveness 4, as the AASM suggests against their standard use due to risk of augmentation 2
  • Avoid other benzodiazepines as they will perpetuate dependence
  • Consider non-pharmacological approaches:
    • Sleep hygiene optimization
    • Cognitive behavioral therapy
    • Regular exercise (but not close to bedtime)

Important Considerations and Pitfalls

  • Monitor for worsening sleep apnea: Clonazepam can mask or worsen sleep apnea, which may become apparent during tapering 3
  • Watch for rebound insomnia: This common withdrawal effect can be confused with or exacerbate RLS symptoms
  • Avoid combining with opioids: Despite some evidence that opioids can help refractory RLS 5, concurrent use with benzodiazepines increases overdose risk 3
  • Consider specialist referral for patients with:
    • Severe RLS symptoms during tapering
    • History of seizures
    • Concurrent psychiatric conditions
    • Failed previous tapering attempts

By recognizing that RLS can emerge during clonazepam tapering and implementing appropriate management strategies, clinicians can help patients successfully discontinue benzodiazepines while minimizing this uncomfortable withdrawal effect.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Benzodiazepine Use and Tapering Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Refractory restless legs syndrome likely caused by olanzapine.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2009

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.